Llewellyn Mills

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Topics

Top Venues

Drug and alcohol review

Journal of psychopharmacology (Oxford, England)

JMIR research protocols

This page only lists publications with an associated author ORCID identifier.

Publications

India Cordony, Llewellyn Mills, Kristie Mammen, Nicholas Lintzeris
A systematic review on the effect of routine outcome monitoring and feedback on client outcomes in alcohol and other drug treatment. Drug and alcohol review (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) (2023)
Llewellyn Mills, Jessica C Lee, Robert A Boakes, Ben Colagiuri
Reduction in caffeine withdrawal after open-label decaffeinated coffee. Journal of psychopharmacology (Oxford, England) 37 (2) (2023)
Lauren Ann Monds, Maria Bravo, Llewellyn Mills, Annie Malcolm, Rosie Gilliver, William Wood, Mary Ellen Harrod, Phillip Read, Suzanne Nielsen, Paul M Dietze, Simon Lenton, Anne M Bleeker, Nicholas Lintzeris
The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions. Drug and alcohol review 41 (5) (2022)
Llewellyn Mills, Nicholas Lintzeris, Michael O'Malley, Jonathon C Arnold, Iain S McGregor
Prevalence and correlates of cannabis use disorder among Australians using cannabis products to treat a medical condition. Drug and alcohol review 41 (5) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review (2022)
Matthew James Coleshill, Peter Andrew Baldwin, Melissa J Black, Jill Maree Newby, Tanya Shrestha, Sam Haffar, Llewellyn Mills, Andrew Stensel, Nicole Cockayne, Jon Tennant, Samuel B Harvey, Helen Christensen
The Essential Network (TEN): Protocol for an Implementation Study of a Digital-First Mental Health Solution for Australian Health Care Workers During COVID-19. JMIR research protocols 11 (3) (2022)
Emma Black, Kristie Mammen, Rachel M Deacon, Nadine Ezard, Llewellyn Mills, Melissa A Jackson, Mark E Montebello, David Reid, Steven Childs, Raimondo Bruno, Anthony P Shakeshaft, Krista J Siefried, Michael Farrell, Jennifer Holmes, Nicholas Lintzeris
Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016-2019. Drug and alcohol review 42 (2) (2022)
Nicholas Lintzeris, Rachel M Deacon, Victoria Hayes, Tracy Cowan, Llewellyn Mills, Laila Parvaresh, Lucy Harvey Dodds, Louisa Jansen, Raelene Dojcinovic, Man Cho Leung, Apo Demirkol, Therese Finch, Kristie Mammen
Opioid agonist treatment and patient outcomes during the COVID-19 pandemic in south east Sydney, Australia. Drug and alcohol review (2021)
Kristie Mammen, Llewellyn Mills, Rachel M Deacon, Raimondo Bruno, Melissa A Jackson, Jennifer Holmes, Jennifer Luksza, Anthony Shakeshaft, Michael Farrell, Nicholas Lintzeris
Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions. Drug and alcohol review (2021)
Rachel M Deacon, Kristie Mammen, Jennifer Holmes, Melissa A Jackson, Raimondo Bruno, Llewellyn Mills, Robert Graham, Nicholas Lintzeris
Assessing the validity of the Australian Treatment Outcomes Profile for telephone administration in drug health treatment populations. Drug and alcohol review 39 (5) (2020)
Llewellyn Mills, Nicholas Lintzeris, Raimondo Bruno, Mark Montebello, Adrian Dunlop, Rachel M Deacon, Jan Copeland, Meryem Jefferies, Consuelo Rivas, Kristie Mammen
Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and alcohol review 39 (4) (2020)
Llewellyn Mills, Robert A Boakes, Ben Colagiuri
The effect of dose expectancies on caffeine withdrawal symptoms during tapered dose reduction. Journal of psychopharmacology (Oxford, England) 33 (8) (2018)